Exocrine Pancreatic Insufficiency (EPI) Market Overview And Statistic For 2024-2033

The Business Research Company's Exocrine Pancreatic Insufficiency Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LANDON, GREATER LANDON, UK, June 24, 2024 /EINPresswire.com/ -- The global market for exocrine pancreatic insufficiency (EPI) is witnessing robust growth, driven by factors such as increased awareness and diagnosis, a growing prevalence of digestive disorders, an aging population, and pancreatic function decline. EPI, characterized by insufficient production or release of digestive enzymes by the pancreas, can lead to malnutrition and various digestive symptoms. The market is projected to grow from $2.41 billion in 2023 to $3.34 billion in 2028, at a compound annual growth rate (CAGR) of 6.5%.

Rising Cases of Diabetes Fuel Market Growth
One of the key drivers of the EPI market is the rising incidence of diabetes. Diabetes, a chronic health condition characterized by inadequate insulin production or utilization, often requires pancreatic enzyme replacement treatment (PERT) to manage EPI. With the global diabetes cases expected to reach 1.3 billion by 2050, up from 529 million in 2022, the demand for PERT and related treatments is set to increase significantly, driving the growth of the EPI market.

Explore comprehensive insights into the global exocrine pancreatic insufficiency (EPI) market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13107&type=smp

Major Players and Market Trends
Leading companies in the EPI market, such as Pfizer Inc., F. Hoffmann-La Roche AG, and Merck & Co. Inc., are focusing on patient-centric product development. For instance, Aimmune Therapeutics, Inc. partnered with Mission: Cure to launch an online patient community, providing crucial support and information to individuals with pancreatitis and EPI.

Segments Driving Market Growth
The exocrine pancreatic insufficiency market covered in this report is segmented –
1) By Treatment: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Other Treatments
2) By Diagnosis: Imaging Tests, Computed Tomography (CT) Scan, Abdominal Ultrasound, Secretin Pancreatic Function Test, Fecal Fat Test, Fecal Elastase Test (FE-1), Other Types
3) By Symptoms: Abdominal Pain, Constipation, Diarrhea, Fatty Stools, Weight Loss, Other Symptoms
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End Users: Hospitals, Specialty Clinics, Homecare

Regional Insights
North America led the EPI market in 2023, with Asia-Pacific expected to be the fastest-growing region in the forecast period. The comprehensive report provides detailed insights into regional dynamics, market trends, and growth opportunities.

Access the complete report for an in-depth analysis of the global exocrine pancreatic insufficiency (EPI) market:
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report

Exocrine Pancreatic Insufficiency Global Market Report 2024 from TBRC covers the following information:
1. Market size data for the forecast period: Historical and Future
2. Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
3. Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Exocrine Pancreatic Insufficiency Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on exocrine pancreatic insufficiency market size, exocrine pancreatic insufficiency market drivers and trends, exocrine pancreatic insufficiency market major players, competitors' revenues, market positioning, and market growth across geographies. The exocrine pancreatic insufficiency market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report

Acute Pancreatitis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acute-pancreatitis-global-market-report

Encephalitis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn